dihexa human data clinical trials EllieMD De-identifying Data in Clinical Trials

10.1002/ddr.21274 Drug Dev

Its long action profile supports a single weekly subcutaneous dose , holding steady exposure between injections and making once-weekly administration practical [3]

Where it crosses the middle scales youll read: Add % to your normal takeoff distance. % decrease in rate of climb. Important: The chart shows percent changes , not final values

What testing method are you using to prove this

Injectable delivery achieves tissue concentrations 10-20 times higher than topical application

Patient outcome scale: after the treatment period, patients were asked on a five-point scale whether they perceived an effect of the treatment